JLL Income Property Trust Declares 16th Consecutive

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
JLL Income Property Trust Declares 16th Consecutive Quarterly Dividend

CHICAGO, IL--(Marketwired - Nov 12, 2015) - JLL Income Property Trust (the "Company"), an institutionally-managed, non-listed, daily valued perpetual life REIT ( NASDAQ : ZIPTAX ) ( NASDAQ : ZIPTMX ) ( NASDAQ : ZIPIAX ) ( NASDAQ : ZIPIMX ), announced that on November 5, 2015 its board of directors declared a regular quarterly dividend of $0.12 per share for the fourth quarter 2015. The Company has paid sixteen consecutive quarterly dividends to its stockholders beginning with the first quarter 2012.

The dividend is payable on or around February 5, 2016 to stockholders of record on December 30, 2015. On an annualized basis, this gross dividend is equivalent to $0.48 per share and represents a yield of approximately 4.3% on a NAV per share of $11.27 as of November 6, 2015. All stockholders will receive $0.12 per share less applicable share class specific fees and the annualized yield will differ based on the share class.

"We continue to offer to our investors dividend payments fully covered by cash flow from operations and at one of the highest dividend coverage ratios in the non-listed REIT industry. Offering an attractive level of current income for distribution to our stockholders is one of our primary investment objectives. In addition, we continue to see opportunities to acquire high quality, income-producing properties to add to our portfolio for that purpose," commented Allan Swaringen, President and CEO of JLL Income Property Trust.

A third quarter dividend of $0.12 per share, less applicable share class specific fees, was paid according to the table below on November 6, 2015 to stockholders of record as of the close of business on September 29, 2015.

                 
    M-I Share 1   A-I Share 2   M Share 3   A Share 4
Q3 Quarterly Gross Dividend per Share   $0.12000   $0.12000   $0.12000   $0.12000
Less: Dealer Manager Fee per Share   ($0.00123)   ($0.00791)   ($0.00797)   ($0.02499)
Q3 Quarterly Net Dividend per Share   $0.11877   $0.11209   $0.11203   $0.09501
NAV per Share as of September 29, 2015   $11.24   $11.23   $11.23   $11.19
Annualized Net Dividend Yield Based on NAV as of September 29, 2015   4.2%   4.0%   4.0%   3.4%
                 

1 A dealer manager fee equal to 1/365th of 0.05% of NAV is allocated to Class M-I stockholders daily and reduces the quarterly dividend paid.

2 A dealer manager fee equal to 1/365th of 0.30% of NAV is allocated to Class A-I stockholders daily and reduces the quarterly dividend paid.

3 A dealer manager fee equal to 1/365th of 0.30% of NAV is allocated to Class M stockholders daily and reduces the quarterly dividend paid.

4 A dealer manager fee equal to 1/365th of 1.05% of NAV is allocated to Class A stockholders daily and reduces the quarterly dividend paid.

JLL Income Property Trust is a non-listed, daily valued perpetual life real estate investment trust (REIT) that gives investors access to a growing portfolio of commercial real estate investments selected by an institutional investment management team and sponsored by one of the world's leading real estate services firms.

For more information on JLL Income Property Trust, please visit our website at www.jllipt.com .

About JLL Income Property Trust ( NASDAQ : ZIPTAX ) ( NASDAQ : ZIPTMX ) ( NASDAQ : ZIPIAX ) ( NASDAQ : ZIPIMX ) Jones Lang LaSalle Income Property Trust, Inc. is a non-listed, daily valued perpetual life real estate investment trust (REIT) that owns and manages a diversified portfolio of high quality, income-producing office, retail, industrial and apartment properties located primarily in the United States. JLL Income Property Trust expects to further diversify its real estate portfolio over time, including on a global basis.

About LaSalle Investment Management LaSalle Investment Management, Inc., a member of the JLL group and advisor to JLL Income Property Trust, is one of the world's leading global real estate investment managers with nearly 700 employees in 16 countries worldwide and approximately $57 billion of assets under management of private and public property equity and debt investments. LaSalle's diverse client base includes public and private pension funds, insurance companies, governments, endowments and private individuals from across the globe. For more information, visit www.lasalle.com .

Forward Looking Statements This press release may contain forward-looking statements with respect to JLL Income Property Trust. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management's intentions, beliefs, expectations, plans or predictions of the future. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from those expressed or implied by such forward-looking statements.

Contact Molly Schlax Telephone +1 312 729 3661 Email Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 125

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
PexarBolt's CES Honor Meets a Real Crowdfunding Test

Updated Category News Views 77

A little touchscreen bolted onto a dock would usually make me roll my eyes. This time, Pexar has at least put enough muscle behind the gimmick to deserve a harder look. The PexarBolt Ultra TBT5 Dock was named a CES Innovation Awards 2027 Honoree in Computer Peripherals & Accessories, following an IFA 2026 Innovation Awards honor only two months after its launch. Awards do...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 72

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 87

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 32

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 100

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 40

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Significant Unusual Options Activity Signals Opportunity in GOOGL

Updated Category News Views 97

Analyzing Recent Options Activity for Alphabet Currently, investors are exhibiting a strong bullish sentiment towards Alphabet (NASDAQ: GOOGL), a trend that is capturing the attention of market participants. Recent observations of public options have revealed significant movements in GOOGL, hinting at potential changes ahead. Recent analyses have uncovered 129 unusual...

Continue Reading
Encore and UKG Introduce Innovative Overtime Savings Program

Updated Category News Views 298

Encore and UKG Join Forces for Employee Financial Wellness Encore, a prominent global leader in event technology and production services, has unveiled an innovative ‘Overtime Savings Program’ in collaboration with UKG, a top provider of HR and workforce management solutions. This remarkable initiative aims to empower Encore's frontline workers, allowing them to save...

Continue Reading
Discover Incredible Returns from Texas Pacific Land Investments

Updated Category News Views 160

The Incredible Growth of Texas Pacific Land Corp Texas Pacific Land Corp (NYSE: TPL) has marked its presence in the market with an outstanding performance over the past 15 years. The company has outshone the market median by an impressive 32.71% annually, which translates to a staggering average annual return of 45.46%. With a current market capitalization nearing $20.51...

Continue Reading
Cypherpunk Q2 2026: Zcash Growth Sparks Market Buzz

Updated Category News Views 76

Cypherpunk Technologies' Stellar Q2 Performance Sit tight, folks, because Cypherpunk Technologies just unleashed a financial update that's got the market buzzing. They've reported a staggering net income of $39.4 million for Q2 2026, quite the turnaround from a $16.6 million loss in the same quarter last year. It's a serious win, no doubt pumped up by their fruitful Zcash...

Continue Reading
Exciting Findings from Aicuris’ Clinical Trials of AIC468

Updated Category News Views 182

Encouraging Insights into AIC468 from Clinical Trials Recently, a notable advancement in medical research has emerged from Aicuris Anti-infective Cures AG regarding its novel treatment, AIC468. This drug is an innovative antisense oligonucleotide targeting the BK virus, particularly in kidney transplant recipients. The first-in-human (FIH) Phase 1 trial has provided...

Continue Reading